rare bleeding disorder drug development

FDA Grants Breakthrough Status to Sutacimig Therapy

CAMBRIDGE, Massachusetts, USA & COPENHAGEN, Denmark — March 5, 2026 Hemab Therapeutics, a clinical-stage biotechnology company focused on developing...

By cGxPwire Editor
March 5, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

rare bleeding disorder drug development

FDA Grants Breakthrough Status to Sutacimig Therapy